PO342 USE OF A MODIFIED EDMONTON OBESITY STAGING SYSTEM (EOSS) TO DISCLOSE PREVIOUSLY UNKNOWN AND UNTREATED COMORBIDITIES AND TO PRIORITIZE TREATMENT STRATEGY IN A JOINT CONSERVATIVE AND BARIATRIC OBESITY AND DIABETES CENTER

Result: 45 people were in each (intervention/control) group; mean age was 51.47±1.05 years in intervention group and 52±1.1 years in control group. There was not a significant difference between mean ages of two groups (p=0.617). 30% of participants were male, 55.6% (15) and 44.4% (12) of them were in intervention group and control group respectively, and 70% of participants were female, 47.6% (30) and 52.4% (33) of themwere in intervention group and control group respectively. After treatment there were no statistically significant difference between MCV, TIBC, FBS, and HbA1C of two groups (p> 0.05, for mean comparison of two groups). In repeated measure ANOVAs analysis, time as within subject effect was significant for all indices, and the change of index between two time points was not the same among the two comparison groups (p< 0.05 for between group and within group interaction terms in repeated measure ANOVAs) for all indices except RBC and FBS, as it is obvious from figure1, the mean reduction of HbA1C from the beginning to the end of the study was greater among intervention group than control. Conclusion: Our results showed that iron deficiency was associated with higher relative of HbA1C, which could cause problems in the diagnosis of uncontrolled diabetes mellitus in IDA patients. The iron status must be considered during the interpretation of the HbA1C concentrations in Diabetes mellitus. The iron supplement therapy is an important in diabetic patients with IDA, as it would also increase the reliability of the HbA1C determinations.